MET and glioma: Results from c-Met ELISA and protein analysis demonstrate that all three c-Met-specific shRNA-expressing Ads (dl/shMet4, dl/shMet5, and dl/shMet4+5) were highly effective in knocking down c-Met expression in multiple glioma cell lines (Figure 2).